N
CFRX

Nuveen’s ContraFect Corporation CFRX Stock Holding History

Nuveen’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,051
Closed -$403K – 3660
2021
Q1 		$403K Sell
1,051
-361
-26% -$156K ﹤0.01% 3129
2020
Q4 		$570K Buy
1,412
+11
+0.8% +$4.76K ﹤0.01% 3013
2020
Q3 		$592K Buy
1,401
+633
+82% +$287K ﹤0.01% 2894
2020
Q2 		$392K Buy
+768
New +$377K ﹤0.01% 2982

Other funds holding CFRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Nuveen's CFRX Position: Q2 2021 in Review

Nuveen sold out of ContraFect Corporation (CFRX) in Q2 2021, closing a stake of 1,051 shares — an estimated $403K sold.

Nuveen first reported a position in CFRX in Q2 2020 and held it in 4 quarters. The position peaked at $592K in Q3 2020. 66 funds tracked by Wall St. Rank hold CFRX as of Q2 2021.

  • Nuveen reported no remaining ContraFect Corporation position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 1,051 ContraFect Corporation shares in Q2 2021, an estimated $403K.
  • Nuveen first reported a position in ContraFect Corporation in Q2 2020 and held it in 4 quarters.
  • Nuveen's ContraFect Corporation position peaked at $592K in Q3 2020.
  • 66 funds tracked by Wall St. Rank held ContraFect Corporation as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.